Testosterone Cypionate Cost in Arkansas (2026): Cash, Insurance & Compounded Prices

What Does Testosterone Cypionate Actually Cost in Arkansas Right Now?

The average cash-pay price for generic testosterone cypionate at Arkansas retail pharmacies sits at approximately $60 per month in 2026. That figure reflects a 1 mL vial of 200 mg/mL concentration, the most commonly dispensed strength for men on testosterone replacement therapy (TRT). Manufacturer list prices for various generics hover near $100 per month, but pharmacy acquisition costs and competitive pricing push the shelf price lower at most Arkansas locations.

Prices vary by pharmacy chain and city. A Walmart in Little Rock may charge differently than an independent pharmacy in Fayetteville. GoodRx-style discount cards can drop cash-pay prices further, sometimes to $30 to $45 for a one-month supply, though these coupons fluctuate. The FDA-approved labeling for testosterone cypionate injection lists the drug as indicated for replacement therapy in males with conditions associated with deficiency or absence of endogenous testosterone [1]. That approval underpins insurance coverage decisions statewide.

For context, the Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, demonstrated that testosterone gel treatment for one year improved sexual function, physical activity, and mood compared with placebo [2]. These findings helped solidify clinical justification for testosterone prescribing across age groups. Cost remains the barrier, not evidence.

Arkansas Medicaid Coverage: Prior Authorization Required

Arkansas Medicaid does cover testosterone cypionate for male hypogonadism, but the program requires prior authorization (PA) before approving the prescription. The PA process typically involves submitting documentation of two morning serum testosterone levels below 300 ng/dL, along with clinical signs or symptoms consistent with hypogonadism [3]. Expect the approval process to take three to five business days.

The Endocrine Society's 2018 clinical practice guideline recommends against diagnosing testosterone deficiency based on a single low reading, instead requiring at least two measurements taken on separate mornings before 10:00 AM [3]. Arkansas Medicaid's PA criteria align with this standard. Dr. Shalender Bhasin, lead author of the Endocrine Society guideline, stated: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone deficiency and unequivocally and consistently low serum testosterone concentrations" [3].

Once approved, Medicaid beneficiaries in Arkansas typically pay $0 to $3 per fill for generic testosterone cypionate. The drug falls under Medicaid's preferred drug list when prescribed for an FDA-approved indication. Denials can be appealed. Common reasons for initial denial include incomplete lab documentation or missing ICD-10 codes. Use E29.1 (testicular hypofunction) as the primary diagnosis code.

Private Insurance: What Arkansas Plans Typically Cover

Most private insurance plans sold in Arkansas, including those on the Health Insurance Marketplace and employer-sponsored plans from Blue Cross Blue Shield of Arkansas, QualChoice, and Ambetter, cover generic testosterone cypionate with varying copay structures. Expect a Tier 2 or Tier 3 generic copay, which ranges from $10 to $40 per month depending on the plan.

Prior authorization requirements vary by insurer. BCBS of Arkansas generally requires two documented low testosterone levels and evidence that the patient has signs of hypogonadism. QualChoice follows a similar protocol. Step therapy is uncommon for injectable testosterone cypionate because the injectable form is already the lowest-cost option in most formularies. Topical gels like AndroGel carry significantly higher price tags, often exceeding $500 per month without insurance [4].

A 2020 analysis published in the Journal of the Endocrine Society found that intramuscular testosterone cypionate cost approximately one-tenth the price of branded testosterone gel formulations on a per-month basis [4]. That cost differential makes the injectable form the default first-line choice from a payer perspective. Arkansas insurers reflect this national pattern.

Compounded Testosterone Cypionate in Arkansas: Legal and Available

Compounded testosterone cypionate is legal in Arkansas when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients when a prescriber determines that a commercially available product does not meet the patient's medical needs [5].

The average cost of compounded testosterone cypionate from an Arkansas 503A pharmacy runs approximately $80 per month. That price may seem counterintuitive since compounded products sometimes cost less than commercial generics. In this case, the compounded product often includes different concentrations (such as 250 mg/mL), combination formulations, or preservative-free options not available in mass-produced vials. Some compounding pharmacies offer multi-month vials that bring the per-month cost down to $50 to $60.

Arkansas does not have additional state-level restrictions beyond federal 503A requirements. The Arkansas State Board of Pharmacy oversees compounding pharmacies and conducts inspections. Patients should verify that their compounding pharmacy holds current state licensure. The FDA has issued warning letters to 503B outsourcing facilities that produced testosterone products with sterility failures [5], reinforcing why pharmacy selection matters.

Telehealth TRT in Arkansas: How It Works and What It Costs

Arkansas permits telehealth prescribing of testosterone cypionate. The state's telemedicine laws allow licensed physicians to evaluate, diagnose, and prescribe controlled substances via audio-video consultation, provided the prescriber holds an active Arkansas medical license or is registered through the Interstate Medical Licensure Compact. A DEA registration valid in Arkansas is also required for Schedule III prescriptions.

Telehealth TRT clinics operating in Arkansas typically charge $99 to $199 per month for a bundled program. These bundles usually include the physician consultation, lab monitoring, and the medication itself (often shipped from a partner 503A pharmacy). Some clinics price the consultation separately at $75 to $150 per visit, with patients filling their prescription at a local pharmacy.

The American Urological Association's 2018 guideline on testosterone deficiency notes that follow-up evaluation should include hematocrit monitoring at 3 to 6 months, then annually, given the dose-dependent risk of erythrocytosis with exogenous testosterone [6]. Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has written: "The critical issue with testosterone therapy is not whether to treat, but to monitor appropriately once treatment begins" [7]. Arkansas telehealth providers should include routine lab panels in their monitoring protocol. If a telehealth clinic does not order hematocrit checks, that is a red flag.

Generic Savings Cards and Discount Programs

Manufacturer savings cards for generic testosterone cypionate work in Arkansas the same way they work nationally. Patients with commercial insurance can use these cards to reduce out-of-pocket costs, sometimes bringing copays to $0. Patients paying cash can also benefit, though the discount structure differs. These cards typically cannot be combined with Medicaid or other federal healthcare programs due to anti-kickback statute restrictions.

GoodRx, RxSaver, and SingleCare all list testosterone cypionate discounts at Arkansas pharmacies. Prices fluctuate weekly, but representative 2026 pricing through these platforms shows:

• Walmart (Little Rock): $28 to $45 for 1 mL of 200 mg/mL
• CVS (Bentonville): $35 to $55 for the same supply
• Walgreens (Fort Smith): $40 to $58 for the same supply

These prices require presenting the discount card at the pharmacy counter. They do not apply if you are using insurance. The two cannot be stacked on the same fill in Arkansas.

Patient assistance programs from generic manufacturers are limited for testosterone cypionate because the drug is already low-cost relative to other hormone therapies. Pfizer's Depo-Testosterone (the branded version) previously offered a copay assistance card, but generic availability has made such programs less common. The NeedyMeds database lists several state and nonprofit programs that may help uninsured Arkansas residents cover prescription costs [8].

How Arkansas Compares to Neighboring States

Arkansas's $60 average cash-pay price for testosterone cypionate sits near the regional median. Missouri averages $55 to $65. Tennessee runs $50 to $60. Texas averages $45 to $55, partly due to higher pharmacy density driving competition. Mississippi tends to run $5 to $10 higher than Arkansas. Oklahoma falls in a similar range to Arkansas.

Medicaid coverage varies more significantly across state lines. While Arkansas requires PA for testosterone cypionate, Tennessee's TennCare program also requires PA but with a more restrictive formulary review. Texas Medicaid covers testosterone cypionate without PA for patients under age 65 with documented hypogonadism. These differences matter for patients living near state borders who might fill prescriptions across state lines, though doing so with controlled substances requires careful attention to DEA and state pharmacy board regulations.

The T-Trials found that testosterone treatment increased coronary artery noncalcified plaque volume, a finding that prompted the FDA to require a cardiovascular risk warning on all testosterone product labels in 2015 [9]. A subsequent larger trial, TRAVERSE (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement in men aged 45 to 80 with hypogonadism and cardiovascular risk factors was noninferior to placebo for major adverse cardiovascular events over a mean follow-up of 33 months [10]. The incidence of the primary cardiovascular endpoint was 7.0% in the testosterone group versus 7.3% in the placebo group (hazard ratio 0.96 to 95% CI 0.78 to 1.17) [10]. This trial reshaped risk-benefit discussions nationwide, including in Arkansas prescribing patterns.

Choosing the Right Option: Decision Factors

The best pricing path depends on your insurance status and clinical situation. Uninsured patients paying cash should compare discount card prices at two or three local pharmacies before filling. Patients with Arkansas Medicaid should have their prescriber submit PA paperwork proactively and use the E29.1 diagnosis code. Patients with private insurance should confirm formulary status and PA requirements before the first fill.

Compounded testosterone cypionate makes sense in specific clinical scenarios: patients who need a concentration not commercially available, patients who require preservative-free formulations due to allergy, or patients whose prescriber prefers subcutaneous micro-dosing protocols with smaller injection volumes. It does not make financial sense for patients who can access generic testosterone cypionate at $30 to $45 through a discount program.

Monitoring costs add to the total expense of TRT. Baseline and follow-up labs (total testosterone, free testosterone, hematocrit, PSA, metabolic panel) run $100 to $300 per panel without insurance. Many Arkansas providers order labs every 3 to 6 months during the first year, then annually. Factor $200 to $600 per year in lab costs on top of medication pricing. Some telehealth programs bundle labs into their monthly fee, which can represent better value for uninsured patients.

The Endocrine Society guideline recommends measuring hematocrit at baseline, at 3 to 6 months, and then annually, with a threshold of 54% for dose reduction or temporary cessation [3]. Arkansas prescribers follow this standard. Skipping lab monitoring to save money is not a safe strategy.